RDY

New York Stock Exchange

Dr. Reddy's Laboratories Ltd. · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$11.36B

PE Ratio

17.5006

EV to Ebitda

11.9702

Earnings Yield

5.71%

Revenue (TTM)

$3.97B

Net Income (TTM)

$644.9M

Revenue (Annual YoY Growth)

14.19%

Revenue (Quarterly YoY Growth)

-1.04%

Profit Margin

16.25%

Return on Equity

15.80%

Debt to Equity Ratio

0.1819

Dividend Yield

0.00%

All fundamentals

Core10 fields›

Market Cap$11.36B

Revenue TTM$3.97B

Shares Outstanding832.6M

Float166509803

Float Short0.39%

Days To Cover5.4614284432

Short Interest13866279.0

Institutional Ownership23.30%

Relative Strength38.5

GARP80

Growth Estimates15 fields›

Revenue Growth (Annual)14.19%

Revenue Growth (Quarterly YoY)-1.04%

Operating Revenue Growth (Annual)0.093523

Operating Revenue Growth (Quarterly YoY)0.101968

3-Year Revenue Growth10.20%

5-Year Revenue Growth9.35%

EPS Growth (Annual)-0.64%

EPS Growth (Quarterly YoY)-18.89%

3-Year EPS Growth Rate28.22%

5-Year EPS Growth Rate19.35%

LT EPS Growth Estimates1.11%

EBITDA Growth (Annual)7.69%

CFO Growth (Annual)0.90%

FCF Growth (Annual)-33.36%

Dividend Growth (Annual)-11.55%

Operations23 fields›

Revenue TTM$3.97B

Gross Margin TTM54.37%

Gross Margin (Quarterly)50.27%

R&D % of Revenue TTM7.38%

R&D Expenses TTM$292.9M

Operating Margin TTM17.95%

Operating Margin (Quarterly)15.82%

Operating Expenses TTM$1.45B

Profit Margin TTM16.25%

Profit Margin (Quarterly)13.63%

Net Income TTM$644.9M

EPS TTM0.7794

EPS (Quarterly)0.1627

EBIT Margin TTM17.95%

EBIT Margin (Quarterly)15.82%

EBITDA Margin TTM23.64%

EBITDA Margin (Quarterly)21.79%

EBITDA TTM$938.1M

CFO % of Revenue TTM14.23%

CFO % of Revenue (Quarterly)11.52%

FCF % of Revenue TTM3.66%

FCF % of Revenue (Quarterly)3.36%

Fundamental Score10

Efficiency5 fields›

ROE15.80%

ROA10.66%

ROIC13.68%

Stock Comp % (Quarterly)0.02%

Stock Comp % TTM0.13%

Valuation17 fields›

P/E (TTM)17.5006

P/E Forward24.0999

P/E Ex-Cash16.0846

P/S Forward2.9981

PEG12.9404

PEG Forward-0.8196

EV/EBITDA (TTM)11.9702

EV/EBITDA Forward14.0537

EV/Revenues (TTM)2.8295

EV/Revenues Forward2.9644

EV/FCF (TTM)124.5013

Price To Book2.7412

Price to Tangible Book4.4303

Earnings Yield5.71%

FCF Yield0.79%

Dividend Yield0.00%

Value Score6

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)0.9235

Relative Profit Margin (Quarterly)2.5379

Relative P/E0.8807

Relative P/S1.2672

Relative P/B1.1109

Relative Earnings Yield1.1354

Relative Dividend Yield0.245

Relative ROE1.1432

Relative ROA1.8851

Relative ROIC1.8022

Relative Debt to Equity0.2905

Liquidity14 fields›

Cash Per Share1.101

Current Ratio1.8795

Cash & ST Assets$918.9M

Total Debt$194.1M

Goodwill & Intangibles$1.28B

Total Assets$6.26B

Total Liabilities$2.08B

Shareholders Equity$4.14B

Debt to Equity0.1819

Debt to Assets12.03%

Interest Expense$38.3M

Times Interest Earned18.6163

Debt to EBITDA (TTM)0.5388

Goodwill % of Assets20.38%

Yields4 fields›

Dividend Yield0.00%

Earnings Yield5.71%

Buyback Yield-0.03%

Shareholder Yield0.34%

Options Flow8 fields›

Call Volume34

Put Volume2

Put/Call Ratio0.058823529411764705

Call $ Volume9307

Put $ Volume286

Put/Call $ Ratio0.030729558396905554

Call OI2059

Put OI1151